Published in Drug Law Weekly, January 26th, 2010
"These effects were not due to GRK2-mediated phosphorylation of the D2 receptor as a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.